Cargando…
CVVHD results in longer filter life than pre-filter CVVH: Results of a quasi-randomized clinical trial
BACKGROUND: Filter clotting is a major issue in continuous kidney replacement therapy (CKRT) that interrupts treatment, reduces delivered effluent dose, and increases cost of care. While a number of variables are involved in filter life, treatment modality is an understudied factor. We hypothesized...
Autores principales: | Mann, Lewis, Ten Eyck, Patrick, Wu, Chaorong, Story, Maria, Jenigiri, Sree, Patel, Jayesh, Honkanen, Iiro, O’Connor, Kandi, Tener, Janis, Sambharia, Meenakshi, Fraer, Mony, Nourredine, Lama, Somers, Douglas, Nizar, Jonathan, Antes, Lisa, Kuppachi, Sarat, Swee, Melissa, Kuo, Elizabeth, Huang, Chou-Long, Jalal, Diana I., Griffin, Benjamin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833553/ https://www.ncbi.nlm.nih.gov/pubmed/36630406 http://dx.doi.org/10.1371/journal.pone.0278550 |
Ejemplares similares
-
Comparison of pre-filter and post-filter ionised calcium monitoring in continuous veno-venous hemodiafiltration (CVVHD-F) with citrate anti-coagulation
por: Brain, Matthew J., et al.
Publicado: (2017) -
Dialyzer clearance of myoglobin with middle molecule filter and low blood flow CVVHD in patients with rhabdomyolysis-associated acute kidney injury
por: Leppanen, I, et al.
Publicado: (2013) -
Impact of CVVHD on pulmonary gas exchange measurement
por: Srámek, V, et al.
Publicado: (1997) -
Impact of CVVH on monocyte activation in the critically ill
por: Rokyta, R, et al.
Publicado: (2000) -
The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
por: Rypulak, E, et al.
Publicado: (2015)